1. Home
  2. VERU vs SGA Comparison

VERU vs SGA Comparison

Compare VERU & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • SGA
  • Stock Information
  • Founded
  • VERU 1971
  • SGA 1986
  • Country
  • VERU United States
  • SGA United States
  • Employees
  • VERU N/A
  • SGA N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • SGA Broadcasting
  • Sector
  • VERU Health Care
  • SGA Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • SGA Nasdaq
  • Market Cap
  • VERU 107.2M
  • SGA 74.4M
  • IPO Year
  • VERU 1990
  • SGA 1992
  • Fundamental
  • Price
  • VERU $0.74
  • SGA $11.89
  • Analyst Decision
  • VERU Strong Buy
  • SGA
  • Analyst Count
  • VERU 4
  • SGA 0
  • Target Price
  • VERU $4.00
  • SGA N/A
  • AVG Volume (30 Days)
  • VERU 1.6M
  • SGA 42.0K
  • Earning Date
  • VERU 02-06-2025
  • SGA 11-07-2024
  • Dividend Yield
  • VERU N/A
  • SGA 8.41%
  • EPS Growth
  • VERU N/A
  • SGA N/A
  • EPS
  • VERU N/A
  • SGA 0.75
  • Revenue
  • VERU $16,886,419.00
  • SGA $110,669,000.00
  • Revenue This Year
  • VERU N/A
  • SGA N/A
  • Revenue Next Year
  • VERU N/A
  • SGA $2.95
  • P/E Ratio
  • VERU N/A
  • SGA $15.84
  • Revenue Growth
  • VERU 3.62
  • SGA N/A
  • 52 Week Low
  • VERU $0.36
  • SGA $10.75
  • 52 Week High
  • VERU $1.92
  • SGA $24.70
  • Technical
  • Relative Strength Index (RSI)
  • VERU 56.66
  • SGA 48.60
  • Support Level
  • VERU $0.63
  • SGA $10.75
  • Resistance Level
  • VERU $0.88
  • SGA $11.89
  • Average True Range (ATR)
  • VERU 0.09
  • SGA 0.43
  • MACD
  • VERU 0.00
  • SGA 0.01
  • Stochastic Oscillator
  • VERU 49.11
  • SGA 48.10

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

About SGA Saga Communications Inc. (FL)

Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets and It derives a majority of its revenue from the sale of advertising for broadcast on its stations.

Share on Social Networks: